Abstract:
A printhead body includes a floor having an interior side and an exterior side. A first set of body vias extend through the floor from the interior side to the exterior side. The first set of body vias is positioned to supply ink to a first micro-fluid ejection chip. A second set of body vias extend through the floor from the interior side to the exterior side. The second set of body vias is positioned to supply ink to a second micro-fluid ejection chip. A plurality of ink flow channels are formed on the interior side of the floor. Each individual ink flow channel of the plurality of ink flow channels is in fluid communication with a particular body via of the first set of body vias and is in fluid communication with a particular body via of the second set of body vias.
Abstract:
A process for alkylation of an alkylatable aromatic compound to produce a monoalkylated aromatic compound, comprising the steps of: (a) providing at least one reaction zone having a water content with at least one catalyst; (b) supplying the reaction zone with at least one alkylatable aromatic compound and at least one alkylating agent; (c) operating the reaction zone under suitable alkylation or transalkylation conditions, to produce at least one effluent which comprises a monoalkylated aromatic compound and a polyalkylated aromatic compound(s); (d) monitoring the amount of the monoalkylated aromatic compound or the amount of the polyalkylated aromatic compound(s) in the effluent; (e) adjusting the water content in the reaction zone to secure a desired amount of the monalkylated aromatic compound or the polyalkylated aromatic compound(s) in the effluent, the water content in the reaction zone being in a range from about 1 wppm to about 900 wppm; and wherein the polyalkylated aromatic compound(s) produced is reduced as compared to the reaction zone having a water content of about 0 wppm when the reaction zone is operated under equivalent conditions.
Abstract:
Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
Abstract:
Water is used to control particle size in a process comprising mixing water with a composition comprising a rheology modifying agent and possibly sugar and cellulose to produce a paste. The paste is extruded to form particles which are then spheronised and dried. One advantage of using water to control particle size is that the number of particles having a diameter within required range, e.g. between from about 800 to about 1500 μm, may be increased.
Abstract:
Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
Abstract:
A stuffed toy equipped with an at least one audio communication device. The toy has a body including a head having a face, a torso and a plurality of limbs. A device for activating a prerecorded message. Another mechanism mounted within the body for playing the prerecorded message and still another device mounted within the body for recording a user generated message including devices mounted in the body for activating and playing such user generated message. Finally, there is a power source electrically connected to provide electrical power to the device for activating the prerecorded message and to mechanism for activating the recording and playing the user generated message.
Abstract:
Disclosed are processes for producing a variant polypeptide (e.g. antibodies) having increased binding affinity for an FcγR, which processes comprise modifying the polypeptides by substitution of the amino acid at position 268 of a human IgG CH2 region for a non-native polar or charged amino acid e.g. Gin, Asn, Glu, or Asp. also provided are corresponding polypeptides, nucleic acids, and methods of use of the same e.g. in improved lytic therapies.
Abstract:
Solid phosphoric acid (SPA) olefin oligomerization process units may be converted to operation with a more environmentally favorable solid catalyst. The SPA units in which a light olefin feed is oligomerized to form gasoline boiling range hydrocarbon product, is converted unit to operation with a molecular sieve based olefin oligomerization catalyst comprising an MWW zeolite material. Besides being more environmentally favorable in use, the MWW based zeolites offer advantages in catalyst cycle life, selectivity. After loading of the catalyst, the converted unit is operated as a fixed-bed unit by passing a C2- C4 olefinic feed and a light aromatic co-feed containing benzene to a fixed bed of the MWW zeolite catalyst to effect alkylation of the benzene with the aromatic co-feed, typically at a temperature from 150 to 350° C., a pressure not greater than 7000 kpa, usually less than 4000 kPa and an olefin space velocity up to 10 WHSV.
Abstract:
A fueling facility and method for dispensing liquid natural gas (LNG), compressed natural gas (CNG) or both on-demand. The fueling facility may include a source of LNG, such as cryogenic storage vessel. A low volume high pressure pump is coupled to the source of LNG to produce a stream of pressurized LNG. The stream of pressurized LNG may be selectively directed through an LNG flow path or to a CNG flow path which includes a vaporizer configured to produce CNG from the pressurized LNG. A portion of the CNG may be drawn from the CNG flow path and introduced into the CNG flow path to control the temperature of LNG flowing therethrough. Similarly, a portion of the LNG may be drawn from the LNG flow path and introduced into the CNG flow path to control the temperature of CNG flowing therethrough.